EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 2.075
March 31, 2026 -0.1541
December 31, 2025 -0.3943
September 30, 2025 1.192
June 30, 2025 0.9601
March 31, 2025 1.029
December 31, 2024 0.8319
September 30, 2024 -2.886
June 30, 2024 -3.119
March 31, 2024 -3.494
December 31, 2023 -3.552
September 30, 2023 -1.682
June 30, 2023 -1.565
March 31, 2023 -1.509
December 31, 2022 -1.437
September 30, 2022 -1.400
June 30, 2022 -1.310
March 31, 2022 -0.9389
December 31, 2021 -0.5817
September 30, 2021 -0.3474
June 30, 2021 -0.1791
March 31, 2021 -0.2889
December 31, 2020 -0.4115
September 30, 2020 -0.4527
June 30, 2020 -0.438
Date Value
March 31, 2020 -0.4775
December 31, 2019 -0.5225
September 30, 2019 -0.5036
June 30, 2019 -0.9983
March 31, 2019 -1.212
December 31, 2018 -1.331
September 30, 2018 -2.368
June 30, 2018 -2.46
March 31, 2018 -2.25
December 31, 2017 -2.21
September 30, 2017 -1.81
June 30, 2017 -1.44
March 31, 2017 -2.02
December 31, 2016 -2.57
September 30, 2016 -2.24
June 30, 2016 -2.27
March 31, 2016 -1.77
December 31, 2015 -1.15
September 30, 2015 -0.7504
June 30, 2015 -0.3404
March 31, 2015 0.0029
December 31, 2014 0.0829
September 30, 2014 -0.0325
June 30, 2014 -0.3425
March 31, 2014 -0.4158

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Natera, Inc. -1.368
Caris Life Sciences, Inc. 0.3723
Myriad Genetics, Inc. -1.199
BioRestorative Therapies, Inc. -1.120
Exagen, Inc. -0.8057